- Home
- INVA vs PDX Comparison
INVA vs PDX Comparison
Compare INVA & PDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVA
- PDX
- Stock Information
- Founded
- INVA 1996
- PDX 2019
- Country
- INVA United States
- PDX NY
- Employees
- INVA N/A
- PDX N/A
- Industry
- INVA Biotechnology: Pharmaceutical Preparations
- PDX Finance/Investors Services
- Sector
- INVA Health Care
- PDX Finance
- Exchange
- INVA Nasdaq
- PDX Nasdaq
- Market Cap
- INVA 1.1B
- PDX 997.0M
- IPO Year
- INVA 2004
- PDX N/A
- Fundamental
- Price
- INVA $17.71
- PDX $22.26
- Analyst Decision
- INVA Buy
- PDX
- Analyst Count
- INVA 5
- PDX 0
- Target Price
- INVA $35.60
- PDX N/A
- AVG Volume (30 Days)
- INVA 767.7K
- PDX N/A
- Earning Date
- INVA 11-06-2025
- PDX 01-01-0001
- Dividend Yield
- INVA N/A
- PDX 4.95%
- EPS Growth
- INVA N/A
- PDX N/A
- EPS
- INVA 0.53
- PDX N/A
- Revenue
- INVA $370,229,000.00
- PDX N/A
- Revenue This Year
- INVA $7.98
- PDX N/A
- Revenue Next Year
- INVA $11.60
- PDX N/A
- P/E Ratio
- INVA $32.96
- PDX N/A
- Revenue Growth
- INVA 12.02
- PDX N/A
- 52 Week Low
- INVA $16.52
- PDX $13.52
- 52 Week High
- INVA $22.00
- PDX $21.05
- Technical
- Relative Strength Index (RSI)
- INVA 46.40
- PDX 29.81
- Support Level
- INVA $17.45
- PDX $22.01
- Resistance Level
- INVA $18.45
- PDX $22.44
- Average True Range (ATR)
- INVA 0.50
- PDX 0.47
- MACD
- INVA 0.12
- PDX -0.01
- Stochastic Oscillator
- INVA 52.42
- PDX 20.90
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
About PDX PIMCO Dynamic Income Strategy Fund of Beneficial Interest
PIMCO Dynamic Income Strategy Fund is a non-diversified, limited-term, closed-end management investment company. It seeks current income as a primary objective and capital appreciation as a secondary objective. The fund makes investments using a dynamic asset allocation plan among multiple sectors in the public and private credit markets globally, including corporate debt, mortgage-related and other asset-backed instruments, government and sovereign debt, taxable municipal bonds, and other fixed, variable, and floating-rate income-producing securities of U.S. and foreign issuers, including emerging market issuers and real estate-related investments.